Decreased D-serine levels in CSF of schizophrenia patients

被引：1
作者：
Amar, S.
Bendikov, I.
Nadri, C.
Panizzutti, R. A.
De Miranda, J.
Wolosker, H.
Agam, G.
机构：
[1] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel
[2] Technion Israel Inst Technol, Haifa, Israel
[3] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2006年 / 16卷
关键词：
D O I：
10.1016/S0924-977X(06)80013-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 3 条
[1]   Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence [J].
Harrison, PJ ;
Weinberger, DR .
MOLECULAR PSYCHIATRY, 2005, 10 (01) :40-68
[2]   D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia [J].
Heresco-Levy, U ;
Javitt, DC ;
Ebstein, R ;
Vass, A ;
Lichtenberg, P ;
Bar, G ;
Catinari, S ;
Ermilov, M .
BIOLOGICAL PSYCHIATRY, 2005, 57 (06) :577-585
[3]   Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels [J].
Yamada, K ;
Ohnishi, T ;
Hashimoto, K ;
Ohba, H ;
Iwayama-Shigeno, Y ;
Toyoshima, M ;
Okuno, A ;
Takao, H ;
Toyota, T ;
Minabe, Y ;
Nakamura, K ;
Shimizu, E ;
Itokawa, M ;
Mori, N ;
Iyo, M ;
Yoshikawa, T .
BIOLOGICAL PSYCHIATRY, 2005, 57 (12) :1493-1503
1